Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.062 AUD | +34.78% | +93.75% | +181.82% |
06-26 | Actinogen Medical Limited Announces the Peer-Reviewed Publication of its Phase 2a Biomarker | CI |
06-26 | Actinogen Medical's Xanamem Drug 'Potentially Slows' Progression of Alzheimer's Disease | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+181.82% | 111M | |
+19.41% | 45.51B | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- ACW Stock
- News Actinogen Medical Limited
- Actinogen Medical to Raise AU$10 Million for Clinical Trial Program; Shares Down 22%